InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (13 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
13
T+90 hit rate
58%
T+90 mean return
+54.4%
Across 24 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Stueland Katherine, Chief Executive Officer. Insider active across 3 companies, notably GeneDx Holdings Corp.. Aggregated, 43 disclosures have been recorded. Breakdown: 1 buy · 13 sells. Total volume traded: €3.7m. History available since 30 April 2021. The latest transaction was filed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations43 total
18,750 sharesClass A Common StockSEC:0001689575-26-000028:0
2,140 sharesClass A Common StockSEC:0001689575-26-000028:1
5,932 sharesClass A Common StockSEC:0001689575-26-000028:2
2,429 sharesClass A Common StockSEC:0001689575-26-000028:3
6,546 sharesClass A Common StockSEC:0001689575-26-000026:0
3,639 sharesClass A Common StockSEC:0001689575-26-000026:1
47,684 shares0Class A Common StockSEC:0001689575-26-000010:0
47,684 shares0Class A Common StockSEC:0001689575-26-000010
3,874 shares0Class A Common StockSEC:0001415889-25-011695:0
2,024 shares@ US$81.15735.0% of flowClass A Common StockSEC:0001415889-25-010535:0
80,000 shares0Class A Common StockSEC:0001415889-25-009193:0
1,078 shares@ US$89.44372.9% of flowClass A Common StockSEC:0001415889-25-008282:0
6,546 shares0Class A Common StockSEC:0001415889-25-007692:0
3,874 shares0Class A Common StockSEC:0001415889-25-002534:0
23,800 shares@ US$93.337971.2% of flowClass A Common StockSEC:0001415889-25-001305:0
2,654 shares@ US$75.47356.4% of flowClass A Common StockSEC:0001415889-25-000836:0
18,750 shares0Class A Common StockSEC:0001415889-24-029771:0
6,547 shares0Class A Common StockSEC:0001415889-24-029016:0
5,497 shares@ US$68.653111.9% of flowClass A Common StockSEC:0001415889-24-027270:0
3,874 shares0Class A Common StockSEC:0001415889-24-025837:0
18,750 shares0Class A Common StockSEC:0001415889-24-023621:0
6,546 shares0Class A Common StockSEC:0001415889-24-023262:0
3,874 shares0Class A Common StockSEC:0001415889-24-020434:0
18,750 shares0Class A Common StockSEC:0001415889-24-017454:0
6,546 shares0Class A Common StockSEC:0001415889-24-016351:0
25 of 43 declarations
About Stueland Katherine
Katherine Stueland is the Chief Executive Officer at GeneDx Holdings Corp. and Invitae Corp. She leads business operations and is responsible for the company's growth strategy. With a strong background in the healthcare sector, Katherine Stueland is committed to innovation and improving the services offered by the companies. Her leadership is essential for achieving performance and development objectives.
